Lasofoxifene (tartrate)
Lasofoxifene (CP-336156) tartrate is an orally active and selective estrogen receptor modulator (SERM) [1]. Lasofoxifene tartrate exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene tartrate can be used for the research of breast cancer and postmenopausal osteoporosis[1][2].
Product Specifications
CAS Number
190791-29-8
Product Name Alternative
CP-336156 (tartrate)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/Lasofoxifene-Tartrate.html
Purity
99.93
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
OC1=CC=C2[C@@H](C3=CC=C(OCCN4CCCC4)C=C3)[C@@H](C5=CC=CC=C5)CCC2=C1.O=C(O)[C@@H](O)[C@H](O)C(O)=O
Molecular Formula
C32H37NO8
Molecular Weight
563.64
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD54 / ICAM-1 (15.2), CF640R conjugate, 0.1mg/mL
